glp-1 obesity drug news weight loss drugs leave users low on key nutrients, study finds A network meta-analysis backed weight-loss

Conversations surrounding the increased use of GLP-1s often center around brand names like Ozempic or Wegovy, but theres a lot more to learn about GLP-1 medication

doi: 10.3389/fcvm.2018.00068, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 56

Several mechanisms may be involved in this potential association, some of which include sudden weight loss and hyperactivity of the hypothalamic-pituitary-adrenal axis

Alongside doctors experience, real-world data on the use and value of AOMs will begin to accrue as more patients are treated, albeit predominately still in the private market

Exendin-4 (E4), a long-acting GLP-1RA, has demonstrated neuroprotective effects in early experimental DR [49, 50]